1. Albain KS, Swinnen LJ, Erickson LC, Stiff PJ, Fisher RI (1990): Cisplatin preceded by concurrent cytarabine and hydroxyurea: A pilot study based on an in vitro model. Cancer Chemother Pharmacol 27:33–40
2. Ali-Osman F, Berger MS, Rajagopal BS, Spence A, Livingston RB (1993): Topoisomerase II inhibition and altered kinetics of formation and repair of nitrosourea and cisplatin-induced DNA interstrand cross-links and cytotoxicity in human glioblastoma cells. Cancer Res 53:5663–5668
3. Anderson WK, Quagliato DA, Haugwitz RD, Narayanan VL, Wolpert-DeFilippes MK (1986): Synthesis, physical properties, and antitumor activity of tetraplatin and related tetra-chloroplatinum (IV) stereoisomers of 1,2-diaminocyclohexane. Cancer Treat Rep 70:997–1002
4. Andrews PA, Mann SC, Velury S, Howell SB (1987): Cisplatin uptake mediated cisplatin-resistance in human ovarian carcinoma cells. In: Platinum and Other Metal Coodination Compounds in Cancer Chemotherapy. Nicolini M, ed. Padua, Italy:Martius Nijhoff Publishing
5. Andrews PA, Howell SB (1990): Cellular pharmacology of cisplatin: Perspective on mechanisms of acquired resistance. Cancer Cells 2:35–43